NovaBridge Biosciences (NBP) Income from Non-Controlling Interests (2024 - 2025)
NovaBridge Biosciences (NBP) posted quarterly Income from Non-Controlling Interests of -$51.6 million for Q4 2025, down 505.41% year-on-year from $12.7 million in Q4 2024, and down 980.92% on a QoQ basis from $5.9 million in Q3 2025.
NovaBridge Biosciences (NBP) Income from Non-Controlling Interests (2024 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Income from Non-Controlling Interests for 2 consecutive years, with -$51.6 million the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - | - |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn | - |
| 10 | NovaBridge Biosciences | 398.82 Mn | 398.82 Mn | - | -51.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -51.57 Mn |
| Sep 30, 2025 | 5.85 Mn |
| Dec 31, 2024 | -8.52 Mn |